Ítalo R. S. Bezerra
Research Subjects
Ítalo R. S. Bezerra has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Renato Sousa Lima
Brazilian Nanotechnology National Laboratory, Brazilian Center for Research in Energy and Materials
2 shared publications Aline M. Pascon
Brazilian Nanotechnology National Laboratory, Brazilian Center for Research in Energy and Materials, Campinas, São Paulo 13083-970, Brazil
1 shared publicationAmanda Cherwin
Department of Chemistry
1 shared publicationAna C. H. Castro
Center for Natural and Human Sciences, Federal University of ABC, Santo André, São Paulo 09210-580, Brazil
1 shared publicationAna L. Scott
Center for Mathematics, Computing and Cognition, Federal University of ABC, Santo André, São Paulo 09210-580, Brazil
1 shared publicationBianca H. V. Fernandes
Medical School, University of Sao Paulo, São Paulo, São Paulo 05403-000, Brazil
1 shared publication
Latest Publications
- 20 November 2025
- Published by American Chemical Society (ACS) in ACS Electrochemistry
- Vol. 1 (12) , 2850-2858
Microfluidic Multiplexed Electrochemical Immunosensor for Quantifying Salivary Biomarkers in Heart Failure
- 20 November 2025
- Published by American Chemical Society (ACS) in ACS Electrochemistry
- Vol. 1 (12) , 2850-2858
Microfluidic Multiplexed Electrochemical Immunosensor for Quantifying Salivary Biomarkers in Heart Failure
- 15 August 2022
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 16 (9) , 14239-14253
Modular Label-Free Electrochemical Biosensor Loading Nature-Inspired Peptide toward the Widespread Use of COVID-19 Antibody Tests
Limitations of the recognition elements in terms of synthesis, cost, availability, and stability have impaired the translation of biosensors into practical use. Inspired by nature to mimic the molecular recognition of the anti-SARS-CoV-2 S protein antibody (AbS) by the S protein binding site, we synthesized the peptide sequence of Asn-Asn-Ala-Thr-Asn-COOH (abbreviated as PEP2003) to create COVID-19 screening label-free (LF) biosensors based on a carbon electrode, gold nanoparticles (AuNPs), and electrochemical impedance spectroscopy. The PEP2003 is easily obtained by chemical synthesis, and it can be adsorbed on electrodes while maintaining its ability for AbS recognition, further leading to a sensitivity 3.4-fold higher than the full-length S protein, which is in agreement with the increase in the target-to-receptor size ratio. Peptide-loaded LF devices based on noncovalent immobilization were developed by affording fast and simple analyses, along with a modular functionalization. From studies by molecular docking, the peptide-AbS binding was found to be driven by hydrogen bonds and hydrophobic interactions. Moreover, the peptide is not amenable to denaturation, thus addressing the trade-off between scalability, cost, and robustness. The biosensor preserves 95.1% of the initial signal for 20 days when stored dry at 4 °C. With the aid of two simple equations fitted by machine learning (ML), the method was able to make the COVID-19 screening of 39 biological samples into healthy and infected groups with 100.0% accuracy. By taking advantage of peptide-related merits combined with advances in surface chemistry and ML-aided accuracy, this platform is promising to bring COVID-19 biosensors into mainstream use toward straightforward, fast, and accurate analyses at the point of care, with social and economic impacts being achieved.
- 15 August 2022
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 16 (9) , 14239-14253
Modular Label-Free Electrochemical Biosensor Loading Nature-Inspired Peptide toward the Widespread Use of COVID-19 Antibody Tests
Limitations of the recognition elements in terms of synthesis, cost, availability, and stability have impaired the translation of biosensors into practical use. Inspired by nature to mimic the molecular recognition of the anti-SARS-CoV-2 S protein antibody (AbS) by the S protein binding site, we synthesized the peptide sequence of Asn-Asn-Ala-Thr-Asn-COOH (abbreviated as PEP2003) to create COVID-19 screening label-free (LF) biosensors based on a carbon electrode, gold nanoparticles (AuNPs), and electrochemical impedance spectroscopy. The PEP2003 is easily obtained by chemical synthesis, and it can be adsorbed on electrodes while maintaining its ability for AbS recognition, further leading to a sensitivity 3.4-fold higher than the full-length S protein, which is in agreement with the increase in the target-to-receptor size ratio. Peptide-loaded LF devices based on noncovalent immobilization were developed by affording fast and simple analyses, along with a modular functionalization. From studies by molecular docking, the peptide-AbS binding was found to be driven by hydrogen bonds and hydrophobic interactions. Moreover, the peptide is not amenable to denaturation, thus addressing the trade-off between scalability, cost, and robustness. The biosensor preserves 95.1% of the initial signal for 20 days when stored dry at 4 °C. With the aid of two simple equations fitted by machine learning (ML), the method was able to make the COVID-19 screening of 39 biological samples into healthy and infected groups with 100.0% accuracy. By taking advantage of peptide-related merits combined with advances in surface chemistry and ML-aided accuracy, this platform is promising to bring COVID-19 biosensors into mainstream use toward straightforward, fast, and accurate analyses at the point of care, with social and economic impacts being achieved.